user avatar
Mammoth Biosciences
@mammothbiosci
Improving lives by reading and writing the code of life.
San Francisco, CA
Joined September 2017
Posts
  • user avatar
    Our recent white paper describes how we’re reconfiguring our #CRISPR-based DETECR platform with readily available components to rapidly detect #SARSCoV2 within 30 minutes. We hope this information will enable better solutions for rapid diagnostics.
  • user avatar
    Read our @medrxivpreprint co-authored with @cychiu98’s lab @UCSF to see how our #CRISPR-based DETECTR lateral flow assay can precisely detect SARS-CoV-2 in real patient samples! #COVID19 #CoronaVirus medrxiv.org/content/10.110…
  • user avatar
    We’re excited to announce we’re collaborating with @Bayer to develop in vivo #geneEditing therapies! This agreement supports our vision of unlocking the full potential of novel #CRISPR systems & strengthens Bayer’s new cell & gene therapy platform. businesswire.com/news/home/2022…
    We're excited to announce we're collaborating with Bayer to develop in vivo gene-editing therapies! Bayer will gain access to our proprietary toolkit of ultra-small Cas enzymes for application across five pre-selected in vivo indications with a first focus on liver diseases.
    We’re excited to be working together with Bayer, building on the technology leap of our novel CRISPR systems, along with Bayer’s expertise in successful drug development. This joint effort has the potential to benefit patients by developing CRISPR-based approaches for the clinic with the appropriate urgency, while ensuring scientific excellence and safety.
~ Peter Nell, Chief Business Officer and Head of Therapeutics Strategy at Mammoth Biosciences
  • user avatar
    Congratulations to Mammoth Co-Founder and CTO, @janiceschen, who has been recognized as one of @techreview’s “Innovators Under 35”! Check out this article to learn more about Janice’s pioneering work in #CRISPR diagnostics and #biotechnology generally:
  • user avatar
    🧬CRISPR proteins shrink, but its potential expands! #NanoCas, featured in @ScienceMagazine, edits NHP muscle via single-AAV delivery – unlocking therapies for hard-to-target diseases. Huge thanks to @jcouzin for covering our research! science.org/content/articl… #CRISPR #Biotech
  • user avatar
    We've updated our white paper, "A protocol for rapid detection of SARS-CoV-2 using CRISPR: SARS-CoV-2 DETECTR." Check it out to learn how our DETECTR platform could be used to detect SARS-CoV-2 #COVIDー19 #COVID19 #CRISPR #Diagnostics #CRISPRDx
  • user avatar
    We’re excited to announce our collaboration w/ @GSKUS to develop an accurate, easy-to-use, fully disposable, rapid & handheld test that consumers & healthcare providers in clinics can use to detect the novel #coronavirus that causes #COVID19. More here: webwire.com/ViewPressRel.a…
  • user avatar
    Congrats to Professor Jennifer Doudna (@doudna_lab), 2020 Nobel Laureate in Chemistry! Professor Doudna Shares the prize with Professor Emmanuelle Charpentier, Managing Director of the Max Planck Unit for the Science of Pathogens in Berlin. #NobelPrize #CRISPR #GenomeEditing
    Graphic congratulating Professor Jennifer Doudna on here 2020 Nobel Prize award. Graphic contains a headshot of professor Doudna on the left and the following text on the right "The 2020 Nobel Prize in Chemistry has been awarded to Jennifer Doudna, Li Ka Shing Chancellor’s Professor of Biomedical Science at UC Berkeley and Mammoth Biosciences Co-Founder, and Professor Emmanuelle Charpentier,  Managing Director of the Max Planck Unit for the Science of Pathogens in Berlin. They’ve been awarded the prize for their roles in 'the development of a method for genome editing.'"
  • user avatar
    In a very special #MammothDigest, we summarize our recent @NatureBiotech paper published in collaboration with @cychiu98 @UCSF: “CRISPR-Cas12―based detection of SARS-CoV-2.” #CRISPR #Diagnostics #COVID19 nature.com/articles/s4158…
  • user avatar
    Today, we’ve unveiled our vision for the world’s first and only CRISPR-enabled platform capable of detecting any biomarker or disease containing DNA or RNA.
  • user avatar
    We’ve reached unicorn status through a successful $195 million series C/D raise! businesswire.com/news/home/2021… This financing and our extremely talented team will supercharge our protein discovery engine and accelerate the creation of next-generation #CRISPR products.
  • user avatar
    Mammoth Co-Founder, Professor Jennifer Doudna on @AmanpourCoPBS discussing how #CRISPR can be used to fight #COVID19
  • user avatar
    Take a quick break this Friday and discover which Cas protein personality best matches your own #CRISPR #Biology #PhDChat #ScienceTwitter
  • user avatar
    Happy #InternationalDayOfWomenInScience! We're incredibly proud of the #WomenInScience and #WomenInEngineering on our team including our Co-Founders Professor Jennifer Doudna and @janiceschen. Meet more of the amazing women on our team in the thread below.